Clinical Trial Update: Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial update for dose-ranging study of R115966 in plaque psoriasis with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• R115966

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2018-01-29